News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 145–180
- Matches
- 602
- Sources here
- 22
- Companies here
- 19
Search results
Stored financial headlines
Active search
602 matching headlines
Ticker or company: RGENMain company stories
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Banco Bilbao Viscaya Argentaria SA ADR (BBVA) adds 7.7% as weekly turnover climbs
The Spanish bank ADR is building a multiweek advance, with the 52-week weekly chart showing pressure still leaning positive.
BBVA
main company
Sharemaestro market context
Trend signal active
52 weeks +57.5% · Next-week setup positive 65.1%
[6-K] Loma Negra Compania Industrial Argentina Sociedad Anonima Current Report (Foreign Issuer)
Loma Negra Compañía Industrial Argentina Sociedad Anónima filed a Form 6-K report with the SEC, indicating it is a foreign private issuer. This report, filed on August 6, 2026, includes an exhibit related to the company's Q2 2026 earnings release. The filing has a …
LOMA
main company
Sharemaestro market context
Price below Trend Line
52 weeks -7.4%
Earnings Flash (LOMA) Loma Negra Reports Q2 Revenue Ps.238.05B
Loma Negra Compañía Industrial Argentina Sociedad Anónima (LOMA) has reported its Q2 revenue as Ps.238.05 billion. The company operates in the construction materials sector, producing and distributing cement, masonry cement, aggregates, and concrete in Argentina and Paraguay. This financial update follows previous earnings calls …
LOMA
main company
Sharemaestro market context
Price below Trend Line
52 weeks -7.4%
Loma Negra Reports 2Q26 results
BUENOS AIRES, Argentina, Aug. 6, 2026 /PRNewswire/ -- Loma Negra, (NYSE: LOMA; BYMA: LOMA), ("Loma Negra" or the "Company"), the leading cement producer in Argentina, today announced results for the three-month period ended June 30, 2026 (our "2Q26 Results"). 2Q26 Key Highlights Net sales …
LOMA
main company
Sharemaestro market context
Price below Trend Line
52 weeks -7.4%
Emergent BioSolutions laying off dozens, shedding real estate as Narcan competition strains profits
Emergent BioSolutions is undergoing significant restructuring, including layoffs and real estate divestment, to cut costs. These measures are a response to increased competition for its key product, Narcan, an over-the-counter opioid overdose reversal spray. The company has been implementing these changes since Joe Papa …
EBS
main company
Sharemaestro market context
Price below Trend Line
52 weeks -50.3% · Next-week setup negative 43.4%
Emergent BioSolutions | 10-Q: Q2 2026 Earnings Report
This article provides the Q2 2026 earnings report for Emergent BioSolutions. It is a quarterly filing (10-Q) that details the company's financial performance during the second quarter of 2026.
EBS
main company
Sharemaestro market context
Price below Trend Line
52 weeks -50.3% · Next-week setup negative 43.4%
Lithium Argentina AG (LAR.US) will release its earnings report before market open on August 11.
Lithium Argentina AG (LAR.US) is scheduled to release its earnings report before the market opens on August 11. Investors and analysts will be watching closely for the company's financial performance.
LAR
main company
Sharemaestro market context
Price below Trend Line
52 weeks +111.8%
Lithium Argentina Secures $220 Million Debt to Fund Cauchari-Olaroz Expansion
Lithium Argentina (TSE:LAR) has secured $220 million in new unsecured debt facilities to expand its Cauchari-Olaroz lithium brine operation in Argentina. This financing, backed by Ganfeng Lithium, will support a planned Stage 2 expansion to increase production by an additional 45,000 tonnes per year …
LAR
main company
Sharemaestro market context
Price below Trend Line
52 weeks +111.8%
Forgent Power Solutions (FPS) is Positioning for Long-Term Success through Innovation and Growth
Conestoga Capital Advisors, an asset management company, released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here. The letter reports a positive market shift towards Small Caps, with the Russell 2000 Index achieving its best first half since 1991 …
FPS
main company
Sharemaestro market context
Stored weekly price path
28 weeks +17.5% · Next-week setup positive 55.4%
argenx Announces Commencement of Tender Offer to Acquire Forte Biosciences, Inc.
argenx SE August 6, 2026 – 7:45 AM ET Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology innovation company today announced that Avena Merger Sub Inc. ("Purchaser"), a wholly-owned subsidiary of argenx BV ("argenx"), has commenced a tender offer to …
Sharemaestro market context Trend signal active 52 weeks +23.7% · Next-week setup negative 39.6%argenx SE: argenx Announces Commencement of Tender Offer to Acquire Forte Biosciences, Inc.
argenx SE announced the commencement of a tender offer to acquire all outstanding shares of Forte Biosciences, Inc. for $77.00 per share in cash. This acquisition will make Forte Biosciences a wholly-owned subsidiary of argenx. Forte's Board of Directors has recommended that shareholders accept …
ARGX
main company
Sharemaestro market context
Trend signal active
52 weeks +29.0% · Next-week setup positive 56.3%
Emergent BioSolutions Inc. 2026: Revenue $234.3M, EPS ($3.49) — 10-Q Summary
Emergent BioSolutions Inc. reported its second-quarter 2026 results, with revenue increasing to $234.3M from $140.9M year-over-year. Despite this growth, the company recorded a net loss of ($180.2M) and diluted EPS of ($3.49), primarily due to a $191M non-cash impairment on NARCAN® intangible assets. The …
EBS
main company
Sharemaestro market context
Price below Trend Line
52 weeks -50.3% · Next-week setup negative 43.4%
Emergent BioSolutions Inc. 2026 Q2 - Results - Earnings Call Presentation (NYSE:EBS) 2026-08-05
Key Points Interested in Emergent Biosolutions Inc.? Here are five stocks we like better. Q2 performance exceeded expectations: Revenue reached $234 million and adjusted EBITDA rose to $97 million, driven by accelerated medical countermeasure deliveries and strong U.S. government contract activity. NARCAN competition is …
EBS
main company
Sharemaestro market context
Price below Trend Line
52 weeks -50.3% · Next-week setup negative 43.4%
Emergent BioSolutions Reports Second Quarter 2026 Financial Results
Emergent BioSolutions announced its second-quarter 2026 financial results, reporting total revenues of $234.3 million, a 66% increase year-over-year, and an adjusted net income of $30.9 million, up 134%. Despite a significant net loss due to a non-cash impairment charge, the company is implementing a …
EBS
main company
Sharemaestro market context
Price below Trend Line
52 weeks -50.3% · Next-week setup negative 43.4%
Emergent records $191.3M non-cash charge related to NARCAN asset group
Emergent BioSolutions reported Q2 2026 total revenues of $234.3 million, a 66% increase year-over-year, driven primarily by higher U.S. government sales of smallpox and other medical countermeasure products. Despite this revenue growth and improved adjusted net income and EBITDA, the company posted a GAAP …
EBS
main company
Sharemaestro market context
Price below Trend Line
52 weeks -50.3% · Next-week setup negative 43.4%
California State Teachers Retirement System Raises Holdings in Repligen Corporation $RGEN
The California State Teachers Retirement System increased its stake in Repligen Corporation (NASDAQ:RGEN) by 22.1% in the first quarter, now holding 61,860 shares valued at $7.3 million. Repligen exceeded analyst expectations with quarterly revenue of $204.13 million and earnings of $0.54 per share, and …
RGEN
main company
Sharemaestro market context
Trend signal active
52 weeks +33.7%
Emergent BioSolutions Commits to Cross-Sector Collaboration Against Biological Threats in an Evolving Global Security Environment
Emergent BioSolutions (NYSE: EBS) emphasizes the critical need for cross-sector collaboration to address evolving biological threats stemming from geopolitical conflicts, AI, and synthetic biology. The company highlights calls from European health officials and AI industry leaders for stronger safeguards and points to recent anthrax-related …
EBS
main company
Sharemaestro market context
Price below Trend Line
52 weeks -50.3% · Next-week setup negative 43.4%
Telecom Argentina SA Class B Revenue Breakdown – BCBA:TECO2
Telecom Argentina SA Class B (BCBA:TECO2) generated 8.33 trillion ARS last year, with its Information and Communications Technology Services segment contributing 5.28 trillion ARS. The majority of the company's revenue, 8.03 trillion ARS, originated from Argentina.
Sharemaestro market context Trend signal active 52 weeks +72.2%Lithium Argentina Closes $220M Debt Facilities | LAR Stock News
Lithium Argentina (LAR) has secured $220 million in new unsecured debt facilities for its Cauchari-Olaroz lithium brine operation, aimed at funding a Stage 2 expansion to add 45,000 tonnes per annum of lithium carbonate equivalent production. The financing includes a $50 million two-year facility …
LAR
main company
Sharemaestro market context
Price below Trend Line
52 weeks +111.8%
Lithium Argentina Announces $220 Million of New Debt Facilities Closed at Cauchari-Olaroz
Lithium Argentina announced the closing of $220 million in new unsecured debt facilities for its Cauchari-Olaroz lithium brine operation. These facilities, consisting of a $50 million and a $170 million credit line, will strengthen the company's financial position and provide funding flexibility for its …
LAR
main company
Sharemaestro market context
Price below Trend Line
52 weeks +111.8%
Moody National Bank Trust Division Makes New Investment in Repligen Corporation $RGEN
Moody National Bank Trust Division has acquired a new stake in Repligen Corporation (NASDAQ:RGEN), purchasing 17,728 shares valued at approximately $2.42 million. This investment comes as institutional investors collectively own 97.64% of the biotechnology company. Repligen recently reported strong quarterly earnings, exceeding analyst expectations …
RGEN
main company
Sharemaestro market context
Trend signal active
52 weeks +33.7%